Asia is a large continent that comprises diverse populations with varying cultures, socioeconomic status, and health literacy levels. Effective preventive cardiology may require differential health care resource allocation and financing models.
Primary Prevention of Cardiovascular Disease in Asia: Challenges: A Narrative Review Read More »
This review aimed to explore the association between metabolically healthy obesity (MHO) and the risk of depression.
In this study, we examine the historical trends of the global, regional, and national prevalence of adult overweight and obesity from 1990 to 2021 and forecast the future trajectories to 2050.
This study aimed to gain a better understanding of tirzepatide for treatment of Japanese patients with obesity disease (BMI ≥25 kg/m2 with excessive fat accumulation) as defined by the Japanese Society for the Study of Obesity.
The pivotal role of nutrition interventions in the context of dyslipidemia and its cardiometabolic implications is discussed in this review, emphasizing evidence-based and personalized approaches.
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk Read More »
Current BMI-based measures of obesity can both underestimate and overestimate adiposity and provide inadequate information about health at the individual level, which undermines medically-sound approaches to health care and policy. This Commission sought to define clinical obesity as a condition of illness that, akin to the notion of chronic disease in other medical specialties, directly results from the effect of excess adiposity on the function of organs and tissues.
Definition and diagnostic criteria of clinical obesity Read More »
This article highlights these and other potential solutions for therapeutic non-adherence and inertia, as discussed at the 2024 Evidence in the Cardiometabolic Environment (EVIDENT) Summit.
The importance of this has been emphasised once again by the Investigators of the Global Burden of Diseases (GBD), in the article published in this issue of Metabolism, showing that metabolic diseases continue to pose significant health challenges, although there are important differences in health burdens that have occurred over the last 30 years.
Reducing the global prevalence of cardiometabolic risk factors: a bet worth winning Read More »
We propose that two key conditions within the CMDs spectrum—heart failure with preserved ejection fraction (HFpEF) and metabolic dysfunction-associated steatotic liver disease (MASLD)—are likely to play a substantial role in shaping cardiometabolic research and healthcare priorities in the near future.
The evolving landscape of cardiometabolic diseases Read More »
This review explores recent advancements in our understanding of CVD in women. We summarise the underlying factors unique to women that can promote CVD risk factors, ultimately contributing to CVD burden and the emerging therapies aimed to combat this.
This site is only for use by healthcare professionals.
By continuing to view this site you are confirming that you are a healthcare professional.
